Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Glenn Miles, Roy Smythe, Steve Ziganti, More

Glenn Miles
Cancer Genetics has appointed Glenn Miles as its CFO, effective Nov, 26. In addition, the company said that Igor Gitelman, its current chief accounting officer, will be departing.

Miles has more than 30 years' experience in a variety of accounting and finance roles and has been a full time contractor with Cancer Genetics since July. Prior to joining Cancer Genetics, he served as president and CFO of management advisory firm Catalytic Consulting, was biopharma controller for Europe, Latin America, and US oncology at Pfizer, and held various senior-level finance positions at Lehman Brothers and AT&T Mobility.

Roy Smythe
Roy Smythe has been appointed CEO of SomaLogic. He will replace Alister Reynolds, who became CEO in early 2017 and who will remain on the company's board. Smythe joins the Boulder, Colorado-based firm from Royal Philips, where he served as chief medical officer for strategy and partnerships. He has also served as CMO at Valence Health and CMO at healthcare technology accelerator AVIA. Previously, he was chair of the department of surgery at Baylor Scott & White Health and the Texas A&M Health Science Center College of Medicine, where he held the position of medical director of innovation.

Steve Ziganti, Patrik Jeanmonod, Jack Ball, Allen Poirson
Steve Ziganti has joined Cytek Biosciences as VP of worldwide sales and Patrik Jeanmonod has been hired as the firm's CFO. Additionally, Jack Ball and Allen Poirson have joined the board of directors.

Ziganti previously served as VP of sales and service at BD Biosciences before retiring from that firm. Jeanmonod has previously held executive positions in finance at Covance, Bridge Pharmaceuticals, and Synteract. He is currently a board member at Seal Biosciences. Ball was previously the CEO of Amnis and chief commercial officer of Accuri Cytomers and Molecular Probes. Poirson is a partner at Mighty Capital and previously served as CEO of Sony Biotechnology.

For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.